Status | Study |
Completed |
Study Name: Pregnancy Outcomes in Women With Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin Condition: Recurrent Pregnancy Loss Date: 2014-05-16 Interventions: Drug: Heparin Group A (n = 100) are put on Inj. UFH (Cal-heparin) 5000 U subcutaneous twice daily plusAs |
Completed |
Study Name: The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage Condition: Circulating Cell Free Fetal DNA Intrauterine Fetal Demise Date: 2013-08-02 |
Completed |
Study Name: Vascular Endothelial Growth Factor Levels at Hysteroscopic Biopsies Which Taken From Recurrent Pregnancy Loss Condition: Recurrent Pregnancy Loss Without Current Pregnancy Date: 2012-11-26 |
Recruiting |
Study Name: Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages Condition: Recurrent Pregnancy Loss Date: 2012-07-04 Interventions: Drug: Aspirin Aspirin 75 mg da |
Completed |
Study Name: Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment Condition: Recurrent Pregnancy Loss Date: 2012-02-25 |
Completed |
Study Name: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome Condition: Fetal Demise Fetal Growth Restriction Date: 2010-01-20 Interventions: Drug: enoxaparin enoxaparin dosage will be adjusted according to anti-factor Xa plasma levels |
Recruiting |
Study Name: Venous Thromboembolism in Pregnancy Study Condition: Venous Thromboembolism Intrauterine Fetal Death Date: 2009-03-04 |
Completed |
Study Name: Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy Condition: Recurrent Pregnancy Loss Fetal Demise Date: 2008-07-22 |
Completed |
Study Name: Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy Condition: Intrauterine Fetal Demise Date: 2008-04-29 Interventions: Drug: Misoprostol 200 mcg bucc |
Completed |
Study Name: Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity Condition: Pregnancy Complications Preeclampsia Placental Abruption Date: 2007-12-12 |